Daily policy & regulation roundup: 6 stories curated September 25, 2026. Lead: Unregulated Peptides Have Flooded the Market. Will Regulators Respond?.

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Unregulated Peptides Have Flooded the Market. Will Regulators Respond?.
Members of the molecular and clinical genetics panel said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings.
Follow the full firehose on the HTC Wire, refreshed automatically every day.